Cargando…

Cellular immunity against SARS-CoV-2 is predominantly boosted in vaccinated individuals with no history of infection

Detalles Bibliográficos
Autores principales:	Favresse, Julien, Cabo, Julien, Douxfils, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197432/ https://www.ncbi.nlm.nih.gov/pubmed/37211218 http://dx.doi.org/10.1016/j.jinf.2023.05.014

Ejemplares similares

Importance of sample dilution in the evaluation of the antibody response after SARS-CoV-2 vaccination
por: Favresse, Julien, et al.
Publicado: (2021)

Post-SARS-CoV-2 vaccination specific antibody decrease — Thresholds for determining seroprevalence and seroneutralization differ
por: Douxfils, Jonathan, et al.
Publicado: (2021)

Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity
por: Favresse, Julien, et al.
Publicado: (2022)

Reply to Schulte-Pelkum, J. Comment on “Favresse et al. Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection. Microorganisms 2021, 9, 556”
por: Favresse, Julien, et al.
Publicado: (2021)

Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects
por: Gillot, Constant, et al.
Publicado: (2021)

Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)
por: Favresse, Julien, et al.
Publicado: (2021)

Clinical performance evaluation of the Fluorecare® SARS-CoV-2 & Influenza A/B & RSV rapid antigen combo test in symptomatic individuals
por: Bayart, Jean-Louis, et al.
Publicado: (2023)

Efficient Maternal to Neonate Transfer of Neutralizing Antibodies after SARS-CoV-2 Vaccination with BNT162b2: A Case-Report and Discussion of the Literature
por: Douxfils, Jonathan, et al.
Publicado: (2021)

Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection
por: Favresse, Julien, et al.
Publicado: (2021)

An Original ELISA-Based Multiplex Method for the Simultaneous Detection of 5 SARS-CoV-2 IgG Antibodies Directed against Different Antigens
por: Gillot, Constant, et al.
Publicado: (2020)

Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination
por: Douxfils, Jonathan, et al.
Publicado: (2021)

Comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders”
por: Favresse, Julien, et al.
Publicado: (2019)

NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments
por: Gillot, Constant, et al.
Publicado: (2021)

Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity
por: Favresse, Julien, et al.
Publicado: (2022)

Vaccine‐induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster
por: Favresse, Julien, et al.
Publicado: (2022)

Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia Syndrome
por: Gillot, Constant, et al.
Publicado: (2022)

High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies
por: Mairesse, Antoine, et al.
Publicado: (2020)

Analytical Sensitivity of Six SARS-CoV-2 Rapid Antigen Tests for Omicron versus Delta Variant
por: Bayart, Jean-Louis, et al.
Publicado: (2022)

Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection
por: Favresse, Julien, et al.
Publicado: (2021)

Cellular immunity against SARS-CoV-2 depends on the serological status
por: Pighi, Laura, et al.
Publicado: (2023)

Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2
por: Favresse, Julien, et al.
Publicado: (2021)

Longitudinal analysis of the evolution of cellular immunity to SARS-CoV-2 induced by infection and vaccination
por: Vasileiou, Spyridoula, et al.
Publicado: (2022)

Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses
por: Anft, Moritz, et al.
Publicado: (2022)

Comparison of analytical performances between clot waveform analysis and FibWave in edoxaban‐treated patients and healthy controls
por: Evrard, Jonathan, et al.
Publicado: (2022)

Immune Response Post–SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Receiving Belatacept
por: Noble, Johan, et al.
Publicado: (2021)

Lung Transplant Recipients Immunogenicity after Heterologous ChAdOx1 nCoV-19—BNT162b2 mRNA Vaccination
por: Catry, Emilie, et al.
Publicado: (2022)

The Effects of Heterologous Immunization with Prime-Boost COVID-19 Vaccination against SARS-CoV-2
por: Ho, Tzu-Chuan, et al.
Publicado: (2021)

Antibody titres decline 3-month post-vaccination with BNT162b2
por: Favresse, Julien, et al.
Publicado: (2021)

Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021
por: Thangaraj, Jeromie Wesley Vivian, et al.
Publicado: (2022)

Vaccination of susceptible animals against SARS-CoV-2
por: Xiang, Bin, et al.
Publicado: (2022)

Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS‐CoV‐2 vaccine
por: Xu, Xingli, et al.
Publicado: (2022)

Long‐term effects of homologous and heterologous SARS‐CoV‐2 vaccination on humoral and cellular immune responses
por: Hollstein, Moritz M., et al.
Publicado: (2022)

Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients
por: Blazquez-Navarro, Arturo, et al.
Publicado: (2021)

Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves’ disease
por: Sriphrapradang, Chutintorn
Publicado: (2021)

SARS-CoV-2 Infection in Fully Vaccinated Individuals of Old Age Strongly Boosts the Humoral Immune Response
por: Müller, Lisa, et al.
Publicado: (2021)

Modular capsid decoration boosts adenovirus vaccine-induced humoral immunity against SARS-CoV-2
por: Dicks, Matthew D.J., et al.
Publicado: (2022)

Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults
por: Liu, Xiaoqiang, et al.
Publicado: (2022)

Time of day influences immune response to an inactivated vaccine against SARS-CoV-2
por: Zhang, Hui, et al.
Publicado: (2021)

Hashimoto encephalopathy after vaccination against SARS-CoV-2
por: Viscasillas Sancho, M., et al.
Publicado: (2022)

In-depth analysis of T cell immunity and antibody responses in heterologous prime-boost-boost vaccine regimens against SARS-CoV-2 and Omicron variant
por: Heinen, Natalie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4186i0u634bskbtihlckqmluqn